Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO16886 | Amorpha fruticosa | Species | Fabaceae | Eukaryota |
PMID[8326318] |
|||
NPO16886 | Amorpha fruticosa | Species | Fabaceae | Eukaryota |
PMID[8350086] |
|||
NPO401 | Berchemia discolor | Species | Rhamnaceae | Eukaryota | Tanzania |
PMID[17125241] |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT91 | Cell Line | KB | Homo sapiens | ED50 | < | 0.001 | ug/ml | DrugMatrix in vitro pharmacology data |
NPT1034 | Cell Line | Lu1 | Homo sapiens | ED50 | = | 3.1 | ug/ml | DrugMatrix in vivo data: Pathology |
NPT672 | Cell Line | TE-671 | Homo sapiens | ED50 | < | 0.001 | ug/ml | 16378361 |
NPT2 | Others | Unspecified | Activity | = | 100 | % | 20621475 | |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | < | 0.001 | ug/ml | 17512094 |
NPT81 | Cell Line | A549 | Homo sapiens | ED50 | < | 0.001 | ug/ml | 17512094 |
NPT80 | Cell Line | Raji | Homo sapiens | Activity | = | 80 | % | 15921418 |
NPT83 | Cell Line | MCF7 | Homo sapiens | ED50 | = | 13.1 | ug/ml | 26988298 |
NPT858 | Cell Line | LNCaP | Homo sapiens | ED50 | = | 5.4 | ug/ml | 26988298 |
NPT1091 | Cell Line | RPMI-7951 | Homo sapiens | ED50 | < | 0.001 | ug/ml | 21723121 |
NPT180 | Cell Line | HCT-8 | Homo sapiens | ED50 | < | 0.001 | ug/ml | 21723121 |
NPT2 | Others | Unspecified | Activity | = | 89.7 | % | 20536188 | |
NPT2 | Others | Unspecified | Activity | = | 100 | % | 9873492 | |
NPT80 | Cell Line | Raji | Homo sapiens | Activity | = | 80 | % | DrugMatrix in vitro pharmacology data |
NPT2 | Others | Unspecified | Activity | = | 24.2 | % | 7852999 | |
NPT80 | Cell Line | Raji | Homo sapiens | Activity | = | 80 | % | 17497807 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC121333 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9875 | High Similarity | NPC242395 |
0.9875 | High Similarity | NPC152477 |
0.9691 | High Similarity | NPC74559 |
0.9627 | High Similarity | NPC128293 |
0.9627 | High Similarity | NPC173292 |
0.9576 | High Similarity | NPC156635 |
0.9571 | High Similarity | NPC103307 |
0.9568 | High Similarity | NPC8965 |
0.9565 | High Similarity | NPC234052 |
0.9509 | High Similarity | NPC177480 |
0.9509 | High Similarity | NPC326877 |
0.9448 | High Similarity | NPC150131 |
0.9444 | High Similarity | NPC62261 |
0.9444 | High Similarity | NPC224280 |
0.9401 | High Similarity | NPC67302 |
0.9387 | High Similarity | NPC119589 |
0.9387 | High Similarity | NPC471213 |
0.9383 | High Similarity | NPC124038 |
0.9383 | High Similarity | NPC273959 |
0.9383 | High Similarity | NPC41301 |
0.9333 | High Similarity | NPC279209 |
0.9333 | High Similarity | NPC472276 |
0.9333 | High Similarity | NPC102277 |
0.9329 | High Similarity | NPC477154 |
0.9329 | High Similarity | NPC6588 |
0.9329 | High Similarity | NPC117854 |
0.9321 | High Similarity | NPC474033 |
0.9321 | High Similarity | NPC474034 |
0.9321 | High Similarity | NPC472635 |
0.9321 | High Similarity | NPC220912 |
0.9317 | High Similarity | NPC298093 |
0.9317 | High Similarity | NPC471976 |
0.9273 | High Similarity | NPC288813 |
0.9268 | High Similarity | NPC120593 |
0.9268 | High Similarity | NPC170245 |
0.9264 | High Similarity | NPC472625 |
0.9259 | High Similarity | NPC228383 |
0.9259 | High Similarity | NPC3629 |
0.9259 | High Similarity | NPC472632 |
0.9259 | High Similarity | NPC173137 |
0.9259 | High Similarity | NPC471499 |
0.9259 | High Similarity | NPC308992 |
0.9259 | High Similarity | NPC134783 |
0.9255 | High Similarity | NPC152904 |
0.9255 | High Similarity | NPC473990 |
0.925 | High Similarity | NPC303255 |
0.9235 | High Similarity | NPC473883 |
0.9222 | High Similarity | NPC310794 |
0.9212 | High Similarity | NPC14662 |
0.9212 | High Similarity | NPC158761 |
0.9207 | High Similarity | NPC472277 |
0.9207 | High Similarity | NPC326520 |
0.9207 | High Similarity | NPC50960 |
0.9207 | High Similarity | NPC300053 |
0.9207 | High Similarity | NPC108433 |
0.9207 | High Similarity | NPC470457 |
0.9202 | High Similarity | NPC83922 |
0.9202 | High Similarity | NPC81679 |
0.9202 | High Similarity | NPC472448 |
0.9198 | High Similarity | NPC263449 |
0.9198 | High Similarity | NPC174953 |
0.9198 | High Similarity | NPC282009 |
0.9198 | High Similarity | NPC472624 |
0.9198 | High Similarity | NPC475784 |
0.9198 | High Similarity | NPC470326 |
0.9198 | High Similarity | NPC287328 |
0.9167 | High Similarity | NPC108202 |
0.9157 | High Similarity | NPC165456 |
0.9152 | High Similarity | NPC235610 |
0.9152 | High Similarity | NPC477517 |
0.9152 | High Similarity | NPC113093 |
0.9146 | High Similarity | NPC18100 |
0.9146 | High Similarity | NPC473313 |
0.9146 | High Similarity | NPC470459 |
0.9146 | High Similarity | NPC329669 |
0.9146 | High Similarity | NPC472278 |
0.9146 | High Similarity | NPC475985 |
0.9146 | High Similarity | NPC236521 |
0.9146 | High Similarity | NPC472281 |
0.9146 | High Similarity | NPC152659 |
0.9146 | High Similarity | NPC205265 |
0.9146 | High Similarity | NPC248638 |
0.9141 | High Similarity | NPC474038 |
0.9141 | High Similarity | NPC167678 |
0.9141 | High Similarity | NPC266314 |
0.9141 | High Similarity | NPC289771 |
0.9141 | High Similarity | NPC471212 |
0.9141 | High Similarity | NPC472634 |
0.9141 | High Similarity | NPC471210 |
0.9141 | High Similarity | NPC165549 |
0.9141 | High Similarity | NPC471211 |
0.9141 | High Similarity | NPC26326 |
0.9141 | High Similarity | NPC29876 |
0.9136 | High Similarity | NPC95936 |
0.9136 | High Similarity | NPC22192 |
0.9136 | High Similarity | NPC55738 |
0.9136 | High Similarity | NPC250214 |
0.9136 | High Similarity | NPC187792 |
0.9102 | High Similarity | NPC44558 |
0.9096 | High Similarity | NPC470456 |
0.9096 | High Similarity | NPC295082 |
0.9096 | High Similarity | NPC247973 |
0.9096 | High Similarity | NPC474024 |
0.9096 | High Similarity | NPC260266 |
0.9096 | High Similarity | NPC243877 |
0.9091 | High Similarity | NPC293319 |
0.9091 | High Similarity | NPC275780 |
0.9091 | High Similarity | NPC72787 |
0.9091 | High Similarity | NPC36 |
0.9091 | High Similarity | NPC36916 |
0.9091 | High Similarity | NPC7688 |
0.9091 | High Similarity | NPC472450 |
0.9091 | High Similarity | NPC125039 |
0.9091 | High Similarity | NPC239752 |
0.9091 | High Similarity | NPC58223 |
0.9091 | High Similarity | NPC7154 |
0.9085 | High Similarity | NPC476247 |
0.9085 | High Similarity | NPC474150 |
0.9085 | High Similarity | NPC474162 |
0.9085 | High Similarity | NPC261470 |
0.9085 | High Similarity | NPC25152 |
0.9085 | High Similarity | NPC472402 |
0.9085 | High Similarity | NPC229632 |
0.908 | High Similarity | NPC118256 |
0.908 | High Similarity | NPC119209 |
0.908 | High Similarity | NPC472962 |
0.908 | High Similarity | NPC472961 |
0.908 | High Similarity | NPC472631 |
0.908 | High Similarity | NPC204290 |
0.908 | High Similarity | NPC476980 |
0.908 | High Similarity | NPC470183 |
0.908 | High Similarity | NPC328102 |
0.908 | High Similarity | NPC192686 |
0.908 | High Similarity | NPC472630 |
0.9074 | High Similarity | NPC284820 |
0.9074 | High Similarity | NPC19097 |
0.9074 | High Similarity | NPC473272 |
0.9074 | High Similarity | NPC162869 |
0.9074 | High Similarity | NPC27337 |
0.9074 | High Similarity | NPC210084 |
0.9074 | High Similarity | NPC474055 |
0.9074 | High Similarity | NPC474208 |
0.9074 | High Similarity | NPC262286 |
0.9074 | High Similarity | NPC476981 |
0.9074 | High Similarity | NPC223787 |
0.9074 | High Similarity | NPC78225 |
0.9074 | High Similarity | NPC78071 |
0.9074 | High Similarity | NPC36852 |
0.9074 | High Similarity | NPC474836 |
0.9074 | High Similarity | NPC67876 |
0.9074 | High Similarity | NPC471209 |
0.9074 | High Similarity | NPC48208 |
0.9074 | High Similarity | NPC475267 |
0.9074 | High Similarity | NPC99597 |
0.9074 | High Similarity | NPC52530 |
0.9074 | High Similarity | NPC156057 |
0.9074 | High Similarity | NPC181960 |
0.9074 | High Similarity | NPC291508 |
0.9074 | High Similarity | NPC472598 |
0.9068 | High Similarity | NPC37392 |
0.9059 | High Similarity | NPC168584 |
0.9053 | High Similarity | NPC472607 |
0.9048 | High Similarity | NPC212038 |
0.9048 | High Similarity | NPC81332 |
0.9048 | High Similarity | NPC262580 |
0.9048 | High Similarity | NPC475825 |
0.9048 | High Similarity | NPC223375 |
0.9048 | High Similarity | NPC257667 |
0.9048 | High Similarity | NPC289396 |
0.9048 | High Similarity | NPC271848 |
0.9048 | High Similarity | NPC186847 |
0.9048 | High Similarity | NPC472454 |
0.9042 | High Similarity | NPC472383 |
0.9042 | High Similarity | NPC472381 |
0.9036 | High Similarity | NPC277480 |
0.9036 | High Similarity | NPC39091 |
0.9036 | High Similarity | NPC470462 |
0.9036 | High Similarity | NPC472449 |
0.903 | High Similarity | NPC474240 |
0.903 | High Similarity | NPC7483 |
0.903 | High Similarity | NPC306321 |
0.903 | High Similarity | NPC189473 |
0.903 | High Similarity | NPC303460 |
0.903 | High Similarity | NPC186686 |
0.903 | High Similarity | NPC472582 |
0.903 | High Similarity | NPC23298 |
0.9024 | High Similarity | NPC474239 |
0.9024 | High Similarity | NPC474186 |
0.9024 | High Similarity | NPC61010 |
0.9024 | High Similarity | NPC198829 |
0.9024 | High Similarity | NPC474187 |
0.9024 | High Similarity | NPC142252 |
0.9024 | High Similarity | NPC259456 |
0.9018 | High Similarity | NPC53545 |
0.9018 | High Similarity | NPC117418 |
0.9018 | High Similarity | NPC204879 |
0.9018 | High Similarity | NPC195832 |
0.9012 | High Similarity | NPC291878 |
0.9012 | High Similarity | NPC250922 |
0.9012 | High Similarity | NPC35038 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC121333 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9317 | High Similarity | NPD5494 | Approved |
0.9091 | High Similarity | NPD6167 | Clinical (unspecified phase) |
0.9091 | High Similarity | NPD6168 | Clinical (unspecified phase) |
0.9091 | High Similarity | NPD6166 | Phase 2 |
0.8896 | High Similarity | NPD3882 | Suspended |
0.8889 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8827 | High Similarity | NPD1934 | Approved |
0.8773 | High Similarity | NPD2801 | Approved |
0.8757 | High Similarity | NPD3818 | Discontinued |
0.8721 | High Similarity | NPD4338 | Clinical (unspecified phase) |
0.8704 | High Similarity | NPD4380 | Phase 2 |
0.8655 | High Similarity | NPD7074 | Phase 3 |
0.8614 | High Similarity | NPD7075 | Discontinued |
0.8613 | High Similarity | NPD7808 | Phase 3 |
0.8606 | High Similarity | NPD3817 | Phase 2 |
0.8605 | High Similarity | NPD6797 | Phase 2 |
0.8596 | High Similarity | NPD7054 | Approved |
0.8596 | High Similarity | NPD5844 | Phase 1 |
0.8555 | High Similarity | NPD7251 | Discontinued |
0.8547 | High Similarity | NPD7472 | Approved |
0.8545 | High Similarity | NPD7096 | Clinical (unspecified phase) |
0.8494 | Intermediate Similarity | NPD5402 | Approved |
0.8488 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8485 | Intermediate Similarity | NPD6801 | Discontinued |
0.8462 | Intermediate Similarity | NPD1247 | Approved |
0.8443 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8395 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8393 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8391 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.8344 | Intermediate Similarity | NPD1512 | Approved |
0.8323 | Intermediate Similarity | NPD7819 | Suspended |
0.8274 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.8256 | Intermediate Similarity | NPD3926 | Phase 2 |
0.8246 | Intermediate Similarity | NPD6959 | Discontinued |
0.8239 | Intermediate Similarity | NPD6559 | Discontinued |
0.8221 | Intermediate Similarity | NPD1511 | Approved |
0.8204 | Intermediate Similarity | NPD7411 | Suspended |
0.8198 | Intermediate Similarity | NPD6232 | Discontinued |
0.8171 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8161 | Intermediate Similarity | NPD7473 | Discontinued |
0.8137 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8132 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.8129 | Intermediate Similarity | NPD919 | Approved |
0.811 | Intermediate Similarity | NPD6799 | Approved |
0.8107 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8075 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8075 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8072 | Intermediate Similarity | NPD5403 | Approved |
0.8056 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.8036 | Intermediate Similarity | NPD6599 | Discontinued |
0.8012 | Intermediate Similarity | NPD2796 | Approved |
0.8011 | Intermediate Similarity | NPD3751 | Discontinued |
0.7952 | Intermediate Similarity | NPD5401 | Approved |
0.7912 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7898 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7886 | Intermediate Similarity | NPD3787 | Discontinued |
0.7861 | Intermediate Similarity | NPD3749 | Approved |
0.784 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7831 | Intermediate Similarity | NPD6781 | Approved |
0.7831 | Intermediate Similarity | NPD6778 | Approved |
0.7831 | Intermediate Similarity | NPD6782 | Approved |
0.7831 | Intermediate Similarity | NPD6776 | Approved |
0.7831 | Intermediate Similarity | NPD6777 | Approved |
0.7831 | Intermediate Similarity | NPD6780 | Approved |
0.7831 | Intermediate Similarity | NPD6779 | Approved |
0.7826 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7758 | Intermediate Similarity | NPD2800 | Approved |
0.7751 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.774 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7738 | Intermediate Similarity | NPD2533 | Approved |
0.7738 | Intermediate Similarity | NPD2532 | Approved |
0.7738 | Intermediate Similarity | NPD2534 | Approved |
0.7733 | Intermediate Similarity | NPD37 | Approved |
0.7727 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7717 | Intermediate Similarity | NPD8150 | Discontinued |
0.7709 | Intermediate Similarity | NPD7228 | Approved |
0.7708 | Intermediate Similarity | NPD7435 | Discontinued |
0.7708 | Intermediate Similarity | NPD7696 | Phase 3 |
0.7708 | Intermediate Similarity | NPD7697 | Approved |
0.7708 | Intermediate Similarity | NPD7698 | Approved |
0.7702 | Intermediate Similarity | NPD1240 | Approved |
0.7701 | Intermediate Similarity | NPD4966 | Approved |
0.7701 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7701 | Intermediate Similarity | NPD4965 | Approved |
0.7701 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7683 | Intermediate Similarity | NPD2935 | Discontinued |
0.7665 | Intermediate Similarity | NPD6190 | Approved |
0.765 | Intermediate Similarity | NPD8313 | Approved |
0.765 | Intermediate Similarity | NPD8312 | Approved |
0.7647 | Intermediate Similarity | NPD920 | Approved |
0.7644 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7641 | Intermediate Similarity | NPD7701 | Phase 2 |
0.7614 | Intermediate Similarity | NPD6234 | Discontinued |
0.7607 | Intermediate Similarity | NPD1607 | Approved |
0.7605 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7593 | Intermediate Similarity | NPD943 | Approved |
0.7593 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7593 | Intermediate Similarity | NPD1613 | Approved |
0.7577 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7577 | Intermediate Similarity | NPD7870 | Phase 2 |
0.7566 | Intermediate Similarity | NPD6535 | Approved |
0.7566 | Intermediate Similarity | NPD6534 | Approved |
0.7558 | Intermediate Similarity | NPD3226 | Approved |
0.7545 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7541 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7539 | Intermediate Similarity | NPD7699 | Phase 2 |
0.7539 | Intermediate Similarity | NPD7700 | Phase 2 |
0.7529 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD3750 | Approved |
0.75 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1653 | Approved |
0.7487 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7475 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.7475 | Intermediate Similarity | NPD7874 | Approved |
0.7446 | Intermediate Similarity | NPD7240 | Approved |
0.744 | Intermediate Similarity | NPD1243 | Approved |
0.7439 | Intermediate Similarity | NPD447 | Suspended |
0.7437 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7437 | Intermediate Similarity | NPD7801 | Approved |
0.7437 | Intermediate Similarity | NPD7783 | Phase 2 |
0.7425 | Intermediate Similarity | NPD2344 | Approved |
0.7425 | Intermediate Similarity | NPD2346 | Discontinued |
0.7424 | Intermediate Similarity | NPD8151 | Discontinued |
0.7412 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.741 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.741 | Intermediate Similarity | NPD2799 | Discontinued |
0.7407 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7391 | Intermediate Similarity | NPD5953 | Discontinued |
0.7385 | Intermediate Similarity | NPD6823 | Phase 2 |
0.7381 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7368 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7346 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD230 | Phase 1 |
0.733 | Intermediate Similarity | NPD6844 | Discontinued |
0.7326 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7323 | Intermediate Similarity | NPD7584 | Approved |
0.7308 | Intermediate Similarity | NPD2403 | Approved |
0.7305 | Intermediate Similarity | NPD3748 | Approved |
0.7305 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7293 | Intermediate Similarity | NPD5710 | Approved |
0.7293 | Intermediate Similarity | NPD5711 | Approved |
0.7292 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7292 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7288 | Intermediate Similarity | NPD8455 | Phase 2 |
0.7284 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7283 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7282 | Intermediate Similarity | NPD7907 | Approved |
0.7278 | Intermediate Similarity | NPD2424 | Discontinued |
0.7268 | Intermediate Similarity | NPD4111 | Phase 1 |
0.7268 | Intermediate Similarity | NPD4665 | Approved |
0.7267 | Intermediate Similarity | NPD7390 | Discontinued |
0.7262 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7262 | Intermediate Similarity | NPD6100 | Approved |
0.7262 | Intermediate Similarity | NPD6099 | Approved |
0.7257 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7256 | Intermediate Similarity | NPD2313 | Discontinued |
0.7256 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7256 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7251 | Intermediate Similarity | NPD2309 | Approved |
0.7238 | Intermediate Similarity | NPD8127 | Discontinued |
0.7229 | Intermediate Similarity | NPD1933 | Approved |
0.7222 | Intermediate Similarity | NPD8319 | Approved |
0.7222 | Intermediate Similarity | NPD8320 | Phase 1 |
0.7202 | Intermediate Similarity | NPD7033 | Discontinued |
0.7198 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7193 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7193 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7191 | Intermediate Similarity | NPD5760 | Phase 2 |
0.7191 | Intermediate Similarity | NPD5761 | Phase 2 |
0.7186 | Intermediate Similarity | NPD6651 | Approved |
0.7158 | Intermediate Similarity | NPD5242 | Approved |
0.7157 | Intermediate Similarity | NPD2493 | Approved |
0.7157 | Intermediate Similarity | NPD2494 | Approved |
0.7135 | Intermediate Similarity | NPD2163 | Approved |
0.7134 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7128 | Intermediate Similarity | NPD2973 | Approved |
0.7128 | Intermediate Similarity | NPD2975 | Approved |
0.7128 | Intermediate Similarity | NPD7549 | Discontinued |
0.7128 | Intermediate Similarity | NPD2974 | Approved |
0.7126 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7126 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7126 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7126 | Intermediate Similarity | NPD6355 | Discontinued |
0.7125 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7118 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7115 | Intermediate Similarity | NPD8155 | Clinical (unspecified phase) |
0.7108 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7079 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7077 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7077 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7073 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7073 | Intermediate Similarity | NPD9494 | Approved |
0.7071 | Intermediate Similarity | NPD3450 | Approved |
0.7071 | Intermediate Similarity | NPD3452 | Approved |
0.7062 | Intermediate Similarity | NPD6213 | Phase 3 |
0.7062 | Intermediate Similarity | NPD6214 | Clinical (unspecified phase) |
0.7062 | Intermediate Similarity | NPD7458 | Discontinued |
0.7062 | Intermediate Similarity | NPD6212 | Phase 3 |
0.7056 | Intermediate Similarity | NPD5353 | Approved |
0.705 | Intermediate Similarity | NPD4582 | Approved |
PubChem CID   | 44593485 |
ChEMBL   | CHEMBL465761 |
ZINC   |
Molecular Weight:   | 426.13 |
ALogP:   | -1.5385 |
MLogP:   | 3.11 |
XLogP:   | 0.521 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 103.68 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 2 |
# Rings:   | 5 |
# Heavy Atoms:   | 31 |